Differing results, however, have been reported in NAFLD mouse models, in which GSK3β appears to be predominantly inactive as demonstrated by significantly increased GSK3β phosphorylation levels [227,228]. This evidence concerns the gene GSK3B and metabolic dysfunction-associated steatotic liver disease.